Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1K4Y

Crystal Structure of Rabbit Liver Carboxylesterase in Complex with 4-piperidino-piperidine

Summary for 1K4Y
Entry DOI10.2210/pdb1k4y/pdb
DescriptorLIVER CARBOXYLESTERASE, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (5 entities in total)
Functional Keywordshydrolase, esterase, side door, camptothecin, irinotecan
Biological sourceOryctolagus cuniculus (rabbit)
Total number of polymer chains1
Total formula weight60529.10
Authors
Bencharit, S.,Morton, C.L.,Howard-Williams, E.L.,Danks, M.K.,Potter, P.M.,Redinbo, M.R. (deposition date: 2001-10-09, release date: 2002-05-01, Last modification date: 2024-10-09)
Primary citationBencharit, S.,Morton, C.L.,Howard-Williams, E.L.,Danks, M.K.,Potter, P.M.,Redinbo, M.R.
Structural insights into CPT-11 activation by mammalian carboxylesterases.
Nat.Struct.Biol., 9:337-342, 2002
Cited by
PubMed Abstract: Mammalian carboxylesterases cleave the anticancer prodrug CPT-11 (Irinotecan) into SN-38, a potent topoisomerase I poison, and 4-piperidino-piperidine (4PP). We present the 2.5 A crystal structure of rabbit liver carboxylesterase (rCE), the most efficient enzyme known to activate CPT-11 in this manner, in complex with the leaving group 4PP. 4PP is observed bound adjacent to a high-mannose Asn-linked glycosylation site on the surface of rCE. This product-binding site is separated from the catalytic gorge by a thin wall of amino acid side chains, suggesting that 4PP may be released through this secondary product exit pore. The crystallographic observation of a leaving group bound on the surface of rCE supports the 'back door' product exit site proposed for the acetylcholinesterases. These results may facilitate the design of improved anticancer drugs or enzymes for use in viral-directed cancer cotherapies.
PubMed: 11967565
DOI: 10.1038/nsb790
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon